ArticleJournal of clinical medicine2024

Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older.

Deniz Isik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.